Prof. Dr. phil. Stephan G. Schmid

Profil

Zusammenfassung

Prof. Schmid ist Archäologe mit Schwerpunkt auf antike Siedlungen und Stadtentwicklung im Mittelmeerraum und Nahen Osten. Er kombiniert klassische Ausgrabungsmethoden mit modernen Techniken wie Geophysik und digitaler 3D-Dokumentation, um antike Städte wie Petra, Ostia und kyprische Königreiche zu erforschen. Seine Expertise umfasst Bauforschung, Ressourcennutzung in antiken Gesellschaften und die Rekonstruktion von Siedlungsmustern in schwierigen Landschaften.

Skills

Name

Prof. Dr. phil. Stephan G. Schmid

Titel

Prof. Dr. phil.

Fakultät

Kultur-, Sozial- und Bildungswissenschaftliche Fakultät

Institut

Institut für Archäologie

Arbeitsgruppe

Klassische Archäologie

E-Mail

🔒 nur für eingeloggte sichtbarAnmelden

Telefon

🔒 nur für eingeloggte sichtbarAnmelden

HU-FIS-Profil

Quelle ↗

Zuletzt gescrapt

27.6.2026, 01:13:54

• 12. International Conference on the History and Archaeology of Jordan (ICHAJ) (Veranstaltung: 05.-11.05.2013, Berlin)

  Quelle ↗

  Förderer: DFG sonstige Programme Zeitraum: 04/2013 - 06/2013 Projektleitung: Prof. Dr. phil. Stephan G. Schmid

• Antike römische Bauornamentik in Jordanien (II)

  Quelle ↗

  Zeitraum: 07/2008 - 09/2008 Projektleitung: Prof. Dr. phil. Stephan G. Schmid

• Antike römische Bauornamentik in Jordanien (IV)

  Quelle ↗

  Förderer: DFG sonstige Programme Zeitraum: 06/2011 - 08/2011 Projektleitung: Prof. Dr. phil. Stephan G. Schmid

🔒 Das System hat 456 mögliche Industrie-Partner gefunden — Firmen, Scores und Begründungen sind nur für eingeloggte Nutzer:innen sichtbar. Anmelden

• Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells

  2009

  Nature Medicine · 360 Zitationen · DOI

• Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

  2004

  Journal of Clinical Oncology · 257 Zitationen · DOI

  PURPOSE: To determine whether the application of two courses of cisplatin simultaneously with hyperfractionated radiotherapy improves the outcome in locally advanced and/or node-positive nonmetastatic carcinomas of the head and neck, compared with hyperfractionated radiotherapy alone. PATIENTS AND METHODS: From July 1994 to July 2000, 224 patients with squamous cell carcinomas of the head and neck (excluding nasopharynx and paranasal sinus) were randomly assigned to hyperfractionated radiotherapy (median dose, 74.4 Gy; 1.2 Gy twice daily) or the same radiotherapy combined with two cycles of concomitant cisplatin (20 mg/m2 on 5 days of weeks 1 and 5). The primary end point was time to any treatment failure; secondary end points were locoregional failure, metastatic relapse, overall survival, and late toxicity. RESULTS: There was no difference in radiotherapy between both treatment arms (74.4 Gy in 44 days). The full cisplatin dose was applied in 93% and 71% of patients during the first and second treatment cycles, respectively. Acute toxicity was similar in both arms. Median time to any treatment failure was not significantly different between treatment arms (19 months for combined treatment and 16 months for radiotherapy only, respectively) and the failure-free rate at 2.5 years was 45% and 33%, respectively. Locoregional control and distant disease-free survival were significantly improved with cisplatin (log-rank test, P = .039 and .011, respectively). The difference in overall survival did not reach significance (log-rank test, P = .147). Late toxicity was comparable in both treatment groups. CONCLUSION: The therapeutic index of hyperfractionated radiotherapy is improved by concomitant cisplatin.

• Is there a role for positron emission tomography with 18F‐fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma

  2002

  Head & Neck · 179 Zitationen · DOI

  BACKGROUND: The aim of our study was to assess the value of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the staging of clinically nodal negative necks in oral and oropharyngeal squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy and elective neck dissection (END) as "gold standard" for comparison. METHODS: Twelve patients (10 men, 2 women) with oral or oropharyngeal squamous cell carcinoma and no evidence of lymph node metastasis in the physical and radiologic examinations were eligible. At least 24 hours before surgery PET with FDG were performed. The SLN was localized by preoperative lymphoscintigraphy with 99m-Tc-Nanocoll and intraoperative use of a hand-held gamma-probe and selectively excised. All patients then underwent END. RESULTS: SLN and END revealed occult metastasis in 5 of 12 cases. SLN biopsy was accurately feasible in all 12 patients and diagnosed all 5 cases of occult metastasis (sensitivity and specificity of 100%). PET suggested two patients having occult metastasis, of which one turned out to be false positive (sensitivity 25%, specificity 88%). The mean size of the micrometastasis was 1.4 mm (range, 1.2-1.5 mm). CONCLUSIONS: PET with FDG turned out to have a poor sensitivity and specificity in revealing occult metastasis and has no role for the evaluation of otherwise clinically N0 necks. The failure to detect micrometastasis by PET is due to the technical limitations of resolution (4-5 mm). SLN biopsy, with END in cases of positive SLN, provides a highly accurate staging of N0 necks in oral and oropharyngeal carcinoma. Patients with negative SLN could be spared the risks and the morbidity of END.

• Berlin-Brandenburgische Akademie der Wissenschaften

  Einstein Foundation Doctoral Program "Strengthening the Digital Humanities in Ancient Studies" (EFDP-2022-734)

  other

• Berliner Antike Kolleg

  Einstein Foundation Doctoral Program "Strengthening the Digital Humanities in Ancient Studies" (EFDP-2022-734)

  research_institute

• Brandenburgische Technische Universität Cottbus-Senftenberg

  Die Entwicklung des Stadtzentrums von Petra (Jordanien) von hellenistischer bis in byzantinische Zeit

  university